immunomodulatory treatmentNintedanibHospital District of Helsinkiinterstitial lung disease (ILD)connective tissue disease–ILDs
…100 mg two times per day). Twenty-seven (87%) patients received immunomodulatory treatment at the time of PPF.Conclusions In our cohort, the underlying di…